HAB Pharmaceuticals
Analgesic1X30gm
You save ₹59.00 · Inclusive of all taxes
MUSKAPAR TR SPRAY — a topical analgesic spray by HAB Pharmaceuticals; composition: Diclofenac diethylamine 3.32%, Methyl salicylate 10%, Menthol 5%, Alcohol 10%.
Available on order. The seller arranges supply before dispatch.
MUSKAPAR TR SPRAY is presented by HAB Pharmaceuticals as an analgesic spray in bottled packaging. The product facts supplied by the vendor include the full declared composition and confirm origin as India. No further clinical claims, indications, dosing information or safety details were provided in the vendor data. For authoritative instructions on when and how to use this medicine, read the manufacturer’s label and patient leaflet or seek advice from a healthcare professional.
MUSKAPAR TR SPRAY is a medicine marketed under the HAB Pharmaceuticals brand and classified in the Analgesic category. The product form is a spray supplied in a bottle and manufactured in India. The vendor-provided composition lists Diclofenac diethylamine 3.32%, Methyl salicylate 10%, Menthol 5% and Alcohol 10%. The available facts describe product identity, form, packing type and composition. For clinical indications, directions for use, contraindications, adverse effects, interactions and patient-specific guidance, consult the printed product label, the enclosed leaflet, your prescribing doctor or a pharmacist.
The vendor data identify MUSKAPAR TR SPRAY as an analgesic product, but they do not enumerate approved indications or specific medical uses on the label. To determine the product’s intended or approved clinical uses, review the printed product label and the enclosed patient leaflet or consult your prescribing physician or pharmacist. They can confirm whether the product is appropriate for a particular complaint, the expected therapeutic role, and any limitations or cautions that apply to certain patient groups.
According to the vendor facts, MUSKAPAR TR SPRAY is categorized as an analgesic topical spray. The product identity and composition are provided by HAB Pharmaceuticals. The vendor data do not list specific therapeutic claims or approved indications in detail. To understand the expected benefits, approved uses, and how this product may fit into a treatment plan, please consult the product label, the enclosed leaflet, or discuss with your prescribing doctor or pharmacist for clinical and patient-specific information.
DICLOFENAC DIETHYLAMINE 3.32 % + METHYL SALICYFATE 10 % + Menthol 5 % + ALCOHOL 10 %
The vendor information for MUSKAPAR TR SPRAY does not include step-by-step usage instructions or dosing guidance. Users should follow the directions printed on the product label and the patient leaflet enclosed with the packaging. If those materials are not available or you need personalized advice (for frequency, duration, or application technique), consult the prescribing clinician or your pharmacist. Do not rely on this summary for application or dosing decisions; always refer to the official product label and local healthcare professionals.
Specific safety information, contraindications, and warnings were not included in the vendor-supplied facts. For precise safety advice, consult the product label, the patient information leaflet, or contact your prescribing doctor or pharmacist. They can advise on precautions relevant to your health status, possible interactions with other medicines, and any conditions where this product should be avoided. Do not assume suitability from the composition alone; always seek professional guidance when in doubt. The supplier-provided facts for MUSKAPAR TR SPRAY do not include a list of possible side effects, adverse reactions, or contraindications. Because this safety information is not supplied here, refer to the printed product leaflet or label for a complete safety profile. For individual advice about potential adverse effects, interactions with other medicines, or what to do if you experience a reaction, speak with your pharmacist or prescribing physician. If you notice any unexpected symptoms after use, seek medical advice promptly and follow local reporting procedures for suspected drug reactions.
The vendor-supplied facts do not include product warnings or contraindications for MUSKAPAR TR SPRAY. For complete warning information, including contraindications, precautions and special population advice, refer to the official product label, enclosed leaflet, or consult a pharmacist or prescribing physician. They can provide up-to-date, authoritative guidance tailored to your health status and concomitant medications. Information on drug interactions was not provided in the vendor facts. To assess the risk of interactions with other medicines, supplements or medical conditions, consult the product leaflet, your pharmacist, or the prescribing doctor. They can review the full clinical context and advise whether concurrent use with other treatments is appropriate or requires monitoring or adjustment.
The vendor facts for MUSKAPAR TR SPRAY do not state storage conditions or shelf life. Follow storage and expiry instructions printed on the product label or carton. If the label or leaflet is missing or unclear, ask your pharmacist or contact the manufacturer (HAB Pharmaceuticals) for authoritative storage guidance. Retain original packaging to preserve batch and expiry information.
Returns and cancellations follow our return policy. Availability and prescription checks are confirmed at checkout.
MUSKAPAR TR SPRAY is listed as a medicine. Use it only as directed by a registered medical practitioner.
It isn’t marked as prescription-only. Follow your doctor’s or pharmacist’s advice before use.
The vendor facts for MUSKAPAR TR SPRAY do not state storage conditions or shelf life. Follow storage and expiry instructions printed on the product label or carton. If the label or leaflet is missing or unclear, ask your pharmacist or contact the manufacturer (HAB Pharmaceuticals) for authoritative storage guidance. Retain original packaging to preserve batch and expiry information.